This white paper entitled "FIP/AAPS Guidelines to Dissolution/in Vitro Release Testing of Novel/Special Dosage Forms" represents the efforts of pharmaceutical scientists worldwide from academe, industry and the regulatory agency who have participated in several workshops under the auspices of FIP and cosponsored by several scientific societies. The paper has received extensive review by the contributors and the editorial staff of AAPS. As stated in the preamble to the paper, comments are welcome as this topic represents a dynamic one and will be evolving and in transition over the next few years.
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